Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

Gomez, Gabriela Beatriz; Siapka, Mariana; Conradie, Francesca; Ndjeka, Norbert; Garfin, Anna Marie Celina; Lomtadze, Nino; Avaliani, Zaza; Kiria, Nana; Malhotra, Shelly; Cook-Scalise, Sarah; +4 more... Juneja, Sandeep; Everitt, Daniel; Spigelman, Melvin; Vassall, Anna; (2021) Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines. BMJ open, 11 (12). e051521. ISSN 2044-6055 DOI: https://doi.org/10.1136/bmjopen-2021-051521

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmjopen-2021-051521

Abstract

Item Type Article
Faculty and Department Faculty of Public Health and Policy > Dept of Global Health and Development
PubMed ID 34862287
Elements ID 168928

Share

Download

Filename: Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in Sout.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar